UA97139C2 - Normal;heading 1;heading 2;heading 3;2-(5-BROMO-4-(4-CYCLOPROPYLNAPHTHALEN-1-YL)-4H-1,2,4-TRIAZOL-3-YLTHIO)ACETIC ACID AND METHYL ESTER - Google Patents

Normal;heading 1;heading 2;heading 3;2-(5-BROMO-4-(4-CYCLOPROPYLNAPHTHALEN-1-YL)-4H-1,2,4-TRIAZOL-3-YLTHIO)ACETIC ACID AND METHYL ESTER

Info

Publication number
UA97139C2
UA97139C2 UAA200909742A UAA200909742A UA97139C2 UA 97139 C2 UA97139 C2 UA 97139C2 UA A200909742 A UAA200909742 A UA A200909742A UA A200909742 A UAA200909742 A UA A200909742A UA 97139 C2 UA97139 C2 UA 97139C2
Authority
UA
Ukraine
Prior art keywords
heading
acetic acid
cyclopropylnaphthalen
ylthio
triazol
Prior art date
Application number
UAA200909742A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Жан-Люк Жирарде
Юнг-Хио Кох
Original Assignee
Ардеа Биосаенсиз, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ардеа Биосаенсиз, Инк. filed Critical Ардеа Биосаенсиз, Инк.
Publication of UA97139C2 publication Critical patent/UA97139C2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to triazolylsulfanyl acetic acid derivatives. The compounds inhibit several variants of the reverse transcriptase of HIV, and are useful in the treatment of HIV infections.
UAA200909742A 2004-08-25 2005-08-25 Normal;heading 1;heading 2;heading 3;2-(5-BROMO-4-(4-CYCLOPROPYLNAPHTHALEN-1-YL)-4H-1,2,4-TRIAZOL-3-YLTHIO)ACETIC ACID AND METHYL ESTER UA97139C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60421904P 2004-08-25 2004-08-25

Publications (1)

Publication Number Publication Date
UA97139C2 true UA97139C2 (en) 2012-01-10

Family

ID=40908676

Family Applications (2)

Application Number Title Priority Date Filing Date
UAA200909742A UA97139C2 (en) 2004-08-25 2005-08-25 Normal;heading 1;heading 2;heading 3;2-(5-BROMO-4-(4-CYCLOPROPYLNAPHTHALEN-1-YL)-4H-1,2,4-TRIAZOL-3-YLTHIO)ACETIC ACID AND METHYL ESTER
UAA200702491A UA89200C2 (en) 2004-08-25 2005-08-25 S-TRIAZOLYL-α-MERCAPTOACETANILDES AS INHIBITORS OF HIV REVERSE TRANSCRIPTASE

Family Applications After (1)

Application Number Title Priority Date Filing Date
UAA200702491A UA89200C2 (en) 2004-08-25 2005-08-25 S-TRIAZOLYL-α-MERCAPTOACETANILDES AS INHIBITORS OF HIV REVERSE TRANSCRIPTASE

Country Status (3)

Country Link
KR (1) KR100940058B1 (en)
UA (2) UA97139C2 (en)
ZA (1) ZA200702390B (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7642277B2 (en) * 2002-12-04 2010-01-05 Boehringer Ingelheim International Gmbh Non-nucleoside reverse transcriptase inhibitors

Also Published As

Publication number Publication date
KR100940058B1 (en) 2010-02-04
UA89200C2 (en) 2010-01-11
ZA200702390B (en) 2008-10-29
KR20090111357A (en) 2009-10-26

Similar Documents

Publication Publication Date Title
EA200901186A1 (en) S-TRIAZOLYL-α-MERCAPTOACETANILIDES AS AN HIV REVERSIBLE TRANSCRIPTASE INHIBITORS
CY1120473T1 (en) TREATMENT OF URINARY ARTHRITIS AND HYPOTHESIS
TR200201187T2 (en) Benzofenones as inhibitors of reverse transcriptase
JO2282B1 (en) Oxazol derivatives
MY141972A (en) Biaryloxymethylarenecarboxylic acids
AP2005003366A0 (en) Pyrimidine derivatives for the prevention of HIV infection.
WO2006005609A3 (en) Substituted oxindol derivatives and medicaments containing the same
WO2003090690A3 (en) Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such
WO2007134678A3 (en) Triazole derivatives ii
WO2001066564A3 (en) Gamma-secretase inhibitors
WO2006102308A3 (en) Beta-lactamyl vasopressin v1b antagonists
WO2000059902A3 (en) Aryl sulfonyls as factor xa inhibitors
ATE427926T1 (en) CYCLOALKYLAMIN DERIVATIVES
AP2006003514A0 (en) Piperazine derivatives for the treatment of HIV infections.
DK1487444T3 (en) Use of pyridylamides as angiogenesis inhibitors
NL1025067A1 (en) Pyrimidine derivatives for the treatment of abnormal cell growth.
WO2004032846A3 (en) Triazolone and triazolethione derivatives
WO2011085009A3 (en) Polymorphic, crystalline and mesophase forms of sodium 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4h-1,2,4-triazol-3-ylthio)acetate, and uses thereof
WO2001064645A3 (en) Derivatives of quinoline as alpha-2 antagonists
EA200900913A1 (en) TRIAZOLE DERIVATIVE AS A HSP90 INHIBITOR
PL372848A1 (en) 5-substituted 1,1-dioxo-[1,2,5]thiazolidine-3-one derivatives as ptpase 1b inhibitors
AU2003300911A1 (en) Heterocyclic compounds as ccr5 antagonists
WO2008026048A3 (en) Stable injectable pharmaceutical compositions of docetaxel
DE60310767D1 (en) PYRAZOL-3,4-d-PYRIMIDIN DERIVATIVES AND THEIR USE IN THE TREATMENT OF H.PYLORI INFECTIONS
WO2003053971A8 (en) Pyridoquinoxaline antivirals